Return to study ST002985 main page
MB Sample ID: SA323967
| Local Sample ID: | 3Cw* |
| Subject ID: | SU003098 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Age Or Age Range: | < 5 years old |
| Gender: | Male and female |
Select appropriate tab below to view additional metadata details:
Treatment:
| Treatment ID: | TR003107 |
| Treatment Summary: | Two different CMP powder formulations were used, i.e., Nutrilon 1 and Nutrilon Pepti 1 (Nutricia, Amsterdam, The Netherlands). Feces were obtained from 6 children within the original cohort (<2 years old; 50% girls), without a history of antibiotic treatment 6 months prior to donation. Among the 6 participants, 2 children suffered from IgE-CMA, and 2 were designated as healthy controls. In vitro simulation of the gastrointestinal digestion consisted of enzymatic digestion (mouth, stomach, and duodenum) followed by colonic fermentation. |
| Treatment Compound: | Nutrilon 1 and Nutrilon Pepti 1 |
| Treatment Dose: | 920 mg |
| Treatment Doseduration: | 1 |
